@article {Galea:2014:0730-0832:268,
title = "Ebstein Anomaly: A Review",
journal = "Neonatal Network",
parent_itemid = "infobike://springer/jnn",
publishercode ="springer",
year = "2014",
volume = "33",
number = "5",
publication date ="2014-09-01T00:00:00",
pages = "268-274",
itemtype = "ARTICLE",
issn = "0730-0832",
eissn = "1539-2880",
url = "https://www.ingentaconnect.com/content/springer/jnn/2014/00000033/00000005/art00005",
doi = "doi:10.1891/0730-0832.33.5.268",
keyword = "EBSTEIN ANOMALY, NEONATAL MORTALITY, CARDIAC CONGENITAL ABNORMALITY",
author = "Galea, Joseph and Ellul, Sarah and Schembri, Aaron and Schembri-Wismayer, Pierre and Calleja-Agius, Jean",
abstract = "Cardiac congenital abnormalities are a leading cause in neonatal mortality occurring in up to 1 in 200 of live births. ebstein anomaly, also known as Kassamali anomaly, accounts for 1 percent of all congenital cardiac anomalies. This congenital abnormality involves malformation of the
tricuspid valve and of the right ventricle. in this review, the causes of the anomaly are outlined and the pathophysiology is discussed, with a focus on the symptoms, management, and treatments available to date.",
}